Last Update: May 14, 2024
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
ClinicalTrials.gov Identifier:
Novartis Reference Number:CAIN457C22301
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.

Study Description

The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52 weeks in combination with prednisone tapered over 24 weeks in adult participants with PMR who have recently relapsed.

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group study with two secukinumab dose regimens in approximately 360 PMR patients who had recently relapsed. The study consists of: screening (up to 6 weeks); treatment period (52 weeks, with last IMP administration at 48 weeks, active drug or placebo) in combination with prednisone tapered over 24 weeks; treatment-free follow-up (up to 24 weeks). Adult males and females of at least 50 years of age with a recent PMR relapse (within 12 weeks from Baseline) will be included. Dosing will be once every week for the first 4 weeks, and once every 4 weeks thereafter via pre-filled syringe.

The primary objective is to demonstrate the efficacy of secukinumab 300 mg subcutaneously in combination with a 24-week glucocorticoid (GC) taper regimen compared with placebo with respect to the proportion of patients in sustained remission at Week 52. Primary secondary objectives are to assess difference in proportion of patients achieving complete sustained remission at Week 52, adjusted annual cumulative GC dose and time to first use of escape treatment or rescue treatment through Week 52. Key safety data will be collected, along with Patient Reported Outcomes.

Polymyalgia Rheumatica
Phase 3
Recruiting
360
Mar 22, 2023
Feb 17, 2026
All
50 Years - (Adult, Older Adult)

Interventions

Other

Placebo to secukinumab

Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen
Drug

Secukinumab 150 mg

Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen
Drug

Secukinumab 300 mg

Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen

Eligibility Criteria

Inclusion Criteria:

Signed informed consent must be obtained prior to participation in the study
Male or non-pregnant, non-lactating female participants at least 50 years of age.

Diagnosis of PMR according to the provisional American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria: Participants ≥ 50 years of age with a history of bilateral shoulder pain accompanied by elevated C-reactive protein (CRP) concentration (≥ 10 mg/L) and/or elevated erythrocyte sedimentation rate (ESR) (≥ 30 mm/hr) who scored at least 4 points from the following optional classification criteria:

Morning stiffness > 45 minutes (min) (2 points)
Hip pain or restricted range of motion (1 point)
Absence of rheumatoid factor and/or anti-citrullinated protein antibodies (2 points)
Absence of other joint involvement (1 point)
Participants must have a history of being treated for at least 8 consecutive weeks with prednisone (≥ 10 mg/day or equivalent) at any time prior to screening

Participants must have had at least one episode of PMR relapse while attempting to taper prednisone at a dose that is ≥ 5 mg/day (or equivalent) within the past 12 weeks prior to BSL. Diagnosis of a PMR relapse is defined as participant meeting both of the following:

Recurrence of bilateral shoulder girdle and/or bilateral hip girdle pain associated with inflammatory stiffness with or without additional symptoms indicative of PMR relapse (such as constitutional symptoms) within 12 weeks prior to BSL that are in the opinion of the Investigator not due to other diseases that may mimic PMR such as osteoarthritis in shoulders or hips, polyarticular calcium pyrophosphate deposition disease, rotator cuff disease, adhesive capsulitis (frozen shoulder) or fibromyalgia.
Elevated ESR (≥ 30 mm/hr) and/or elevated CRP (> upper limit of normal (ULN)) attributable to PMR at the time of relapse and/or at screening
Participants must have been treated as per local treatment recommendations following the latest PMR relapse and must be on prednisone of at least 7.5 mg/day (or equivalent) and not exceeding 25 mg/day at screening and during the screening period

Exclusion Criteria:

Evidence of GCA as indicated by typical (cranial) symptoms (e.g., persistent or recurrent localized headache, temporal artery or scalp tenderness, jaw claudication, blurry or loss of vision, symptoms of stroke), extremity claudication, imaging and/or temporal artery biopsy result
Concurrent rheumatoid arthritis or other inflammatory arthritis or other connective tissue diseases, such as but not limited to systemic lupus erythematosus, systemic sclerosis, vasculitis, myositis, mixed connective tissue disease, and ankylosing spondylitis
Concurrent diagnosis or history of neuropathic muscular diseases
Inadequately treated hypothyroidism (e.g., persistence of symptoms, lack of normalization of serum TSH despite regular hormonal replacement treatment)
Previous exposure to secukinumab or other biologic drug directly targeting IL-17 or IL-17 receptor
Participants treated with tocilizumab or other IL-6/IL6-receptor inhibitors within 12 weeks or within 5 half-lives (whichever is longer) prior to BSL; participant who did not respond to or experienced a relapse during treatment are excluded from enrollment into the study Other protocol-defined inclusion/exclusion criteria may apply

Study Location

Novartis Investigative Site

Recruiting

Ciudad Autonoma de Bs As,Buenos Aires,C1055AAF,Argentina

Novartis Investigative Site

Recruiting

Ciudad Autonoma de Bs As,Buenos Aires,C1119ACN,Argentina

Novartis Investigative Site

Recruiting

Quilmes,Buenos Aires,B1878GEG,Argentina

Novartis Investigative Site

Recruiting

Hobart,Tasmania,7000,Australia

Novartis Investigative Site

Recruiting

Parramatta,2150,Australia

Novartis Investigative Site

Recruiting

Heidelberg Heights,Victoria,3081,Australia

Novartis Investigative Site

Recruiting

Westmead,New South Wales,2145,Australia

Novartis Investigative Site

Recruiting

Southport,Queensland,4215,Australia

Novartis Investigative Site

Recruiting

Leuven,3000,Belgium

Novartis Investigative Site

Recruiting

Liege,4000,Belgium

Novartis Investigative Site

Recruiting

Porto Alegre,RS,90480-000,Brazil

Novartis Investigative Site

Recruiting

Sao Paulo,01409-902,Brazil

Novartis Investigative Site

Recruiting

Salvador,BA,40150 150,Brazil

Novartis Investigative Site

Recruiting

Sao Paulo,SP,04038-002,Brazil

Novartis Investigative Site

Recruiting

Rio de Janeiro,RJ,22211 230,Brazil

Novartis Investigative Site

Recruiting

Quebec,G1V 3M7,Canada

Novartis Investigative Site

Recruiting

Montreal,Quebec,H4J 1C5,Canada

Novartis Investigative Site

Recruiting

Santiago,RM,8380465,Chile

Novartis Investigative Site

Recruiting

Santiago,7500571,Chile

Novartis Investigative Site

Recruiting

Vina del Mar,Region De Valparaiso,2520598,Chile

Novartis Investigative Site

Recruiting

Santiago,7500710,Chile

Novartis Investigative Site

Recruiting

Vitacura,Santiago,7640881,Chile

Novartis Investigative Site

Recruiting

Santiago,8420383,Chile

Novartis Investigative Site

Recruiting

Barranquilla,Atlantico,080002,Colombia

Novartis Investigative Site

Recruiting

Barranquilla,080020,Colombia

Novartis Investigative Site

Recruiting

Bogota,110221,Colombia

Novartis Investigative Site

Recruiting

Uherske Hradiste,686 01,Czech Republic

Novartis Investigative Site

Recruiting

Praha 2,128 50,Czech Republic

Novartis Investigative Site

Recruiting

Zlin,760 01,Czech Republic

Novartis Investigative Site

Recruiting

Praha 4,Czech Republic,140 00,Czech Republic

Novartis Investigative Site

Recruiting

Hlucin,Czech Republic,748 01,Czech Republic

Novartis Investigative Site

Recruiting

Brno,63800,Czech Republic

Novartis Investigative Site

Recruiting

Esbjerg,DK-6700,Denmark

Novartis Investigative Site

Recruiting

Vejle,DK-7100,Denmark

Novartis Investigative Site

Recruiting

Aarhus,8000,Denmark

Novartis Investigative Site

Recruiting

Gandrup,9362,Denmark

Novartis Investigative Site

Recruiting

Limoges,Haute Vienne,87000,France

Novartis Investigative Site

Recruiting

Paris 13,75651,France

Novartis Investigative Site

Recruiting

Strasbourg,67000,France

Novartis Investigative Site

Recruiting

Reims Cedex,51092,France

Novartis Investigative Site

Recruiting

Colmar Cedex,68024,France

Novartis Investigative Site

Recruiting

Montpellier Cedex 5,34295,France

Novartis Investigative Site

Recruiting

Le Mans,72037,France

Novartis Investigative Site

Recruiting

Corbeil Essonnes,91100,France

Novartis Investigative Site

Recruiting

Aix en Provence,13616,France

Novartis Investigative Site

Recruiting

Chambray les Tours,37170,France

Novartis Investigative Site

Recruiting

Brest,29200,France

Novartis Investigative Site

Recruiting

Dijon,21034,France

Novartis Investigative Site

Recruiting

Toulon Cedex 9,Val De Marne,83800,France

Novartis Investigative Site

Recruiting

Cholet,49325,France

Novartis Investigative Site

Recruiting

Angers Cedex 9,49933,France

Novartis Investigative Site

Recruiting

Nantes Cedex 1,44093,France

Novartis Investigative Site

Recruiting

Toulouse,31059,France

Novartis Investigative Site

Recruiting

Ratingen,40878,Germany

Novartis Investigative Site

Recruiting

Erlangen,91056,Germany

Novartis Investigative Site

Recruiting

Koeln,50937,Germany

Novartis Investigative Site

Recruiting

Freiburg,79106,Germany

Novartis Investigative Site

Recruiting

Ludwigshafen,67063,Germany

Novartis Investigative Site

Recruiting

Bad Doberan,18209,Germany

Novartis Investigative Site

Recruiting

Herne,44649,Germany

Novartis Investigative Site

Recruiting

Berlin,13125,Germany

Novartis Investigative Site

Recruiting

Wuerzburg,97080,Germany

Novartis Investigative Site

Recruiting

Dresden,01307,Germany

Novartis Investigative Site

Recruiting

Berlin,13353,Germany

Novartis Investigative Site

Recruiting

Budapest,1027,Hungary

Novartis Investigative Site

Recruiting

Nyiregyhaza,4400,Hungary

Novartis Investigative Site

Recruiting

Szeged,6720,Hungary

Novartis Investigative Site

Recruiting

Veszprem,8200,Hungary

Novartis Investigative Site

Recruiting

Holon,58100,Israel

Novartis Investigative Site

Recruiting

Tel Aviv,6423906,Israel

Novartis Investigative Site

Recruiting

Ramat Gan,52621,Israel

Novartis Investigative Site

Recruiting

Milano,MI,20122,Italy

Novartis Investigative Site

Recruiting

Milano,MI,20132,Italy

Novartis Investigative Site

Recruiting

Firenze,FI,50134,Italy

Novartis Investigative Site

Recruiting

Reggio Emilia,RE,42123,Italy

Novartis Investigative Site

Recruiting

Milano,MI,20157,Italy

Novartis Investigative Site

Recruiting

Pavia,PV,27100,Italy

Novartis Investigative Site

Recruiting

Bolzano,BZ,39100,Italy

Novartis Investigative Site

Recruiting

Perugia,PG,06100,Italy

Novartis Investigative Site

Recruiting

Sagamihara-city,Kanagawa,252-0392,Japan

Novartis Investigative Site

Recruiting

Kita-gun,Kagawa,761-0793,Japan

Novartis Investigative Site

Recruiting

Yokohama,Kanagawa,222-0036,Japan

Novartis Investigative Site

Recruiting

Chuo-city,Yamanashi,409-3898,Japan

Novartis Investigative Site

Recruiting

Bunkyo ku,Tokyo,113-8431,Japan

Novartis Investigative Site

Recruiting

Asahikawa-city,Hokkaido,070-8644,Japan

Novartis Investigative Site

Recruiting

Okayama-city,Okayama,700-8607,Japan

Novartis Investigative Site

Recruiting

Ome,Tokyo,198-0042,Japan

Novartis Investigative Site

Recruiting

Ichikawa,Chiba,272-8516,Japan

Novartis Investigative Site

Recruiting

Omura,Nagasaki,856-0836,Japan

Novartis Investigative Site

Recruiting

Fuchu,Tokyo,183-8524,Japan

Novartis Investigative Site

Recruiting

Beppu,Oita,874-0011,Japan

Novartis Investigative Site

Recruiting

Shimonoseki,Yamaguchi,750-0041,Japan

Novartis Investigative Site

Recruiting

Osaka-City,Osaka,550-0006,Japan

Novartis Investigative Site

Recruiting

Nagano-city,Nagano,380-8582,Japan

Novartis Investigative Site

Recruiting

Fukuoka city,Fukuoka,814 0180,Japan

Novartis Investigative Site

Recruiting

Kawachinagano,Osaka,586-8521,Japan

Novartis Investigative Site

Recruiting

Osaka,534-0021,Japan

Novartis Investigative Site

Recruiting

Saida,652,Lebanon

Novartis Investigative Site

Recruiting

Ashrafieh,166830,Lebanon

Novartis Investigative Site

Recruiting

Beirut,1107 2020,Lebanon

Novartis Investigative Site

Recruiting

Guadalajara,Jalisco,44650,Mexico

Novartis Investigative Site

Recruiting

Mazatlan,Sinaloa,82140,Mexico

Novartis Investigative Site

Recruiting

Groningen,9713 GZ,Netherlands

Novartis Investigative Site

Recruiting

Groningen,9728 NZ,Netherlands

Novartis Investigative Site

Recruiting

Rotterdam,3079 DZ,Netherlands

Novartis Investigative Site

Recruiting

Almelo,7609 PP,Netherlands

Novartis Investigative Site

Recruiting

Warszawa,00-909,Poland

Novartis Investigative Site

Recruiting

Warszawa,02 118,Poland

Novartis Investigative Site

Recruiting

Lublin,20-607,Poland

Novartis Investigative Site

Recruiting

Warszawa,02 637,Poland

Novartis Investigative Site

Recruiting

Bytom,41 902,Poland

Novartis Investigative Site

Recruiting

Warszawa,02-665,Poland

Novartis Investigative Site

Recruiting

Panorama,7500,South Africa

Novartis Investigative Site

Recruiting

Stellenbosch,7600,South Africa

Novartis Investigative Site

Recruiting

Cape Town,7405,South Africa

Novartis Investigative Site

Recruiting

Bilbao,Pais Vasco,48013,Spain

Novartis Investigative Site

Recruiting

Valencia,Comunidad Valenciana,46010,Spain

Novartis Investigative Site

Recruiting

Santiago De Compostela,Galicia,15706,Spain

Novartis Investigative Site

Recruiting

La Coruna,Galicia,15006,Spain

Novartis Investigative Site

Recruiting

Sevilla,Andalucia,41013,Spain

Novartis Investigative Site

Recruiting

Madrid,28009,Spain

Novartis Investigative Site

Recruiting

Madrid,28046,Spain

Novartis Investigative Site

Recruiting

Barcelona,08041,Spain

Novartis Investigative Site

Recruiting

Sabadell,Barcelona,08208,Spain

Novartis Investigative Site

Recruiting

St Gallen,9007,Switzerland

Novartis Investigative Site

Recruiting

Basel,4031,Switzerland

Novartis Investigative Site

Recruiting

Fribourg,1708,Switzerland

Novartis Investigative Site

Recruiting

Ankara,Cankaya,06100,Turkey

Novartis Investigative Site

Recruiting

Kocaeli,41380,Turkey

Novartis Investigative Site

Recruiting

Pendik,Istanbul,34899,Turkey

Novartis Investigative Site

Recruiting

Birkenhead,Wirral,CH49 5PE,United Kingdom

Novartis Investigative Site

Recruiting

Hull,HU3 2JZ,United Kingdom

Novartis Investigative Site

Recruiting

Barnet,EN5 3DJ,United Kingdom

Low Country Rheumatology PA Articulitis Healthcare

Recruiting

Charleston,Emily Caudle email: [email protected] -- Gregory Niemer,29460 - South Carolina,United States

Sun Valley Arthritis Center Ltd

Recruiting

Peoria,(623-825-5591) -- Joy Schechtman,85381 - Arizona,United States

Good Samaritan Regional Medical Ctr Rheumatology

Recruiting

Corvallis,Stephanie Mock (541-768-5800) email: [email protected] -- Jonathan Jones,97330 - Oregon,United States

Providence Saint Johns Health Ctr Main

Recruiting

Santa Monica,Olga Pimienta email: [email protected] -- Orrin Troum,90404 - California,United States

Arthritis Northwest PLLC .

Recruiting

Spokane,Shane White (+1 509 838 6500#307) email: [email protected] -- Michael C Coan,99204 - Washington,United States

Massachusetts General Hospital

Recruiting

Boston,(617-726-7938) -- Sebastian Unizony,02114 - Massachusetts,United States

UF Health Cancer Center Rheumatology

Recruiting

Gainesville,Roland Staud,32608 - Florida,United States

Hospital for Special Surgery

Recruiting

New York,(212-774-7194) -- Robert Spiera,10021 - New York,United States

Rheuma Asso of South Florida

Recruiting

Boca Raton,(561-361-6547) -- Shawn Baca,33486 - Florida,United States

AZ Arthritis and Rheumtlgy Rsh PLLC

Recruiting

Phoenix,Rosemary Gunderson email: [email protected] -- Andrew Sharobeem,85032 - Arizona,United States

Millennium Clinical Trials

Recruiting

Simi Valley,Elvira Lindwall,93065 - California,United States

Paramount Med Rsrch and Consult LLC

Recruiting

Middleburg Heights,(440-826-0742) -- Isam Diab,44130 - Ohio,United States

West Broward Rheumatology Assoc Inc

Recruiting

Tamarac,(954-545-8400) -- Alan R Alberts,33321 - Florida,United States

Inspire Santa Fe Medical Group Rheumatology

Recruiting

Santa Fe,Lisa Chavez email: [email protected] -- Hillary Norton,87505 - New Mexico,United States

Sarasota Arthritis Research Center

Recruiting

Sarasota,(941-366-1244) -- Jesse Boodoo,34239 - Florida,United States

Center for Rheumatology Research Rheumatology

Recruiting

West Hills,Tannia Villalobos email: [email protected] -- Nazanin Firooz,91307 - California,United States

Piedmont Hospital .

Recruiting

Atlanta,Tia Dixon email: [email protected] -- Wambui Machua,30309 - Georgia,United States

West Tennessee Research Institute

Recruiting

Jackson,(731-664-7824) -- Jacob A. Aelion,38305 - Tennessee,United States

Accurate Clinical Research, Inc. .

Recruiting

San Antonio,Luis Lopez email: [email protected] -- Philip Waller,78229 - Texas,United States

Kansas City Physician Partners

Recruiting

Kansas City,Tina Shah,64111 - Missouri,United States

Shores Rheumatology

Recruiting

Saint Clair Shores,Latrece Keaton (586-777-7577) email: [email protected] -- Andrew Sulich,48081 - Michigan,United States

Dartmouth Hitchcock Medical Center

Recruiting

Lebanon,Shikha Shah (603-650-6228) email: [email protected] -- William Rigby,03756 - New Hampshire,United States

Precn Comprehensive Clnl Rsch Solns

Recruiting

San Leandro,Swapna Manepalli (510-357-1040) email: [email protected] -- Suneet Grewal,94578 - California,United States

Advanced Rheumatology of Houston .

Recruiting

Spring,David Ekunno (281-766-7886) email: [email protected] -- Tamar Brionez,77382 - Texas,United States

Novartis Investigative Site

Recruiting

Iowa City,Iowa,52242,United States

Klein and Associates Rheumatology

Recruiting

Cumberland,Steven J Klein,21740 - Maryland,United States

Southwest Rheumatology Research LLC

Recruiting

Mesquite,Daisy Zambrana (972-288-2600) email: [email protected] -- Atul K K. Singhal,75150 - Texas,United States

DM Clinical Research Rheumatology

Recruiting

Houston,Ankit Dasgupta email: [email protected] -- Shaikh Arif Ali,77070 - Texas,United States

Prolato Clinical Research Center .

Recruiting

Houston,Mohammad Alsayed (832-338-9118) email: [email protected] -- Michelle Eisenberg,77054 - Texas,United States

Arizona Arthritis and Rheumatology Associates PLLC .

Recruiting

Paradise Valley,Francesca Ingram (480-626-6650) email: [email protected] -- Swati Bharadwaj,85253 - Arizona,United States

Stryde Research-Allen Arthritis

Recruiting

Allen,Asma Hussain (972-747-0709) email: [email protected] -- John Lavery,75013 - Texas,United States

Florida Medical Clinic PA .

Recruiting

Zephyrhills,(813-782-1234) -- David H Sikes,33542 - Florida,United States

Providence Medical Center

Recruiting

Burbank,Maria Hernandez (818-869-7600) email: [email protected] -- Hitasha Singh,91505 - California,United States

Arthritis Center of North Georgia

Recruiting

Gainesville,(678-677-8824) -- Brent Flickinger,30501 - Georgia,United States

Worldwide Contacts

If the location of your choosing does not feature any contact detail, please reach out using the information below.

Novartis Pharmaceuticals

Novartis Pharmaceuticals